NO994771D0 - FremgangsmÕte ved fremstilling av oligosakkarider - Google Patents

FremgangsmÕte ved fremstilling av oligosakkarider

Info

Publication number
NO994771D0
NO994771D0 NO994771A NO994771A NO994771D0 NO 994771 D0 NO994771 D0 NO 994771D0 NO 994771 A NO994771 A NO 994771A NO 994771 A NO994771 A NO 994771A NO 994771 D0 NO994771 D0 NO 994771D0
Authority
NO
Norway
Prior art keywords
oligosaccharides
preparation
Prior art date
Application number
NO994771A
Other languages
English (en)
Other versions
NO994771L (no
Inventor
Pedro A Prieto
Karen M Kleman-Leyer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO994771D0 publication Critical patent/NO994771D0/no
Publication of NO994771L publication Critical patent/NO994771L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO994771A 1997-03-31 1999-09-30 Fremgangsmåte ved fremstilling av oligosakkarider NO994771L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/829,010 US5945314A (en) 1997-03-31 1997-03-31 Process for synthesizing oligosaccharides
PCT/US1998/006239 WO1998044145A1 (en) 1997-03-31 1998-03-30 A process for synthesizing oligosaccharides

Publications (2)

Publication Number Publication Date
NO994771D0 true NO994771D0 (no) 1999-09-30
NO994771L NO994771L (no) 1999-09-30

Family

ID=25253280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994771A NO994771L (no) 1997-03-31 1999-09-30 Fremgangsmåte ved fremstilling av oligosakkarider

Country Status (6)

Country Link
US (1) US5945314A (no)
EP (1) EP0972068A1 (no)
JP (1) JP2001518783A (no)
CA (1) CA2284731A1 (no)
NO (1) NO994771L (no)
WO (1) WO1998044145A1 (no)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
WO2000012747A1 (en) * 1998-08-31 2000-03-09 Kurt Nilsson Method for enzymatic synthesis of glycosides, disaccharides, and oligosaccharides
EP1131415A4 (en) * 1998-11-18 2002-09-11 Neose Technologies Inc PRODUCTION OF CHEAP OLIGOSACCHARIDES
FR2796082B1 (fr) * 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
US7863020B2 (en) 2000-06-28 2011-01-04 Glycofi, Inc. Production of sialylated N-glycans in lower eukaryotes
US7598055B2 (en) * 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US8697394B2 (en) * 2000-06-28 2014-04-15 Glycofi, Inc. Production of modified glycoproteins having multiple antennary structures
US7625756B2 (en) 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
EP2322644A1 (en) * 2000-06-28 2011-05-18 GlycoFi, Inc. Methods for producing modified glycoproteins
US6596707B2 (en) 2001-05-24 2003-07-22 Abbott Laboratories Monovalent saccharides and uses thereof
SG159381A1 (en) 2001-10-10 2010-03-30 Novo Nordisk As Remodeling and glycoconjugation of peptides
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7399613B2 (en) * 2001-10-10 2008-07-15 Neose Technologies, Inc. Sialic acid nucleotide sugars
US8008252B2 (en) * 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
US7179617B2 (en) * 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
MXPA04012496A (es) 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Glicoformos del factor vii pegilados.
US20050085441A1 (en) * 2002-10-22 2005-04-21 Leach James L. Use of soluble monovalent oligosaccharides as inhibitors of HIV-1 fusion and replication
US20040077590A1 (en) * 2002-10-22 2004-04-22 Leach James L. Use of soluble monovalent oligosaccharides as inhibitors of HIV-1 fusion and replication
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
CA2519092C (en) 2003-03-14 2014-08-05 Neose Technologies, Inc. Branched water-soluble polymers and their conjugates
WO2004091499A2 (en) * 2003-04-09 2004-10-28 Neose Technologies, Inc. Intracellular formation of peptide conjugates
WO2006127896A2 (en) * 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated factor ix
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
EP1615945B1 (en) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
US7046712B2 (en) * 2003-05-02 2006-05-16 Jds Uniphase Corporation Laser resistant to internal ir-induced damage
ATE540055T1 (de) 2003-05-09 2012-01-15 Biogenerix Ag Zusammensetzungen und verfahren zur herstellung von glykosylierungsmutanten des menschlichen wachstumshormons
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
WO2005030974A1 (ja) * 2003-09-26 2005-04-07 Yamasa Corporation Ｃｍｐ−ｎ−アセチルノイラミン酸の製造法
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20060040856A1 (en) * 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
US7956032B2 (en) * 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US20080318850A1 (en) * 2003-12-03 2008-12-25 Neose Technologies, Inc. Glycopegylated Factor Ix
CN101072789B (zh) 2004-01-08 2013-05-15 生物种属学股份公司 肽的o-连接的糖基化
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
WO2006035057A1 (en) * 2004-09-29 2006-04-06 Novo Nordisk Health Care Ag Modified proteins
HUE026826T2 (en) 2004-10-29 2016-07-28 Ratiopharm Gmbh Modeling and glycopegylation of fibroblast growth factor (FGF)
ES2449195T3 (es) 2005-01-10 2014-03-18 Ratiopharm Gmbh Factor estimulante de colonias de granulocitos glicopegilado
EP1866427A4 (en) * 2005-03-30 2010-09-01 Novo Nordisk As MANUFACTURING PROCESS FOR THE PRODUCTION OF CULTIVE PEPTIDES IN CELL LINES OF INSECTS
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP1888098A2 (en) 2005-05-25 2008-02-20 Neose Technologies, Inc. Glycopegylated erythropoietin formulations
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090305967A1 (en) * 2005-08-19 2009-12-10 Novo Nordisk A/S Glycopegylated factor vii and factor viia
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US7605255B2 (en) 2006-06-29 2009-10-20 Alberta Research Council Inc. Non-animal based lactose
ES2516694T3 (es) * 2006-07-21 2014-10-31 Ratiopharm Gmbh Glicosilación de péptidos a través de secuencias de glicosilación con unión en O
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
US20080207487A1 (en) * 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
PL2144923T3 (pl) 2007-04-03 2013-12-31 Biogenerix Ag Sposoby leczenia z użyciem glikopegilowanego G-CSF
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
WO2009108806A1 (en) 2008-02-27 2009-09-03 Novo Nordisk A/S Conjugated factor viii molecules
IT1392456B1 (it) 2008-12-18 2012-03-09 Inalco Spa Processo per la sintesi di di- o oligosaccaridi l-fucosilati e loro nuovi intermedi 2,3,4-tribenzil-fucosil-derivati.
EP2769726B1 (en) * 2013-02-21 2018-10-31 Jennewein Biotechnologie GmbH Synthetic or recombinant fucosylated Oligosaccarides for use in the treatment of infections
PL2896628T3 (pl) 2014-01-20 2019-03-29 Jennewein Biotechnologie Gmbh Sposób wydajnego oczyszczania obojętnych oligosacharydów ludzkiego mleka (HMO) z fermentacji mikrobiologicznej
KR20160036248A (ko) * 2014-09-25 2016-04-04 서울대학교산학협력단 고함량의 올리고당을 포함하는 건강음료의 제조방법 및 이에 의해 제조된 건강음료
US11248217B2 (en) 2018-08-20 2022-02-15 Rutgers, The State University Of New Jersey Engineered carbohydrate-active enzymes for glycan polymers synthesis
EP3670662A1 (en) 2018-12-20 2020-06-24 Basf Se Enzymatic hexosaminidation of lactose

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219571A (en) * 1978-06-15 1980-08-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing a sweetener
US5541083A (en) * 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
US5180674A (en) * 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5583042A (en) * 1990-04-16 1996-12-10 Neose Pharmaceuticals, Inc. Apparatus for the synthesis of saccharide compositions
CA2148929A1 (en) * 1992-11-27 1994-06-09 Eric G. Berger Proteins having glycosyltransferase activity
US5426178A (en) * 1993-03-31 1995-06-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis of anti-inflammatory compounds, and novel trisaccharides useful in the synthesis of anti-inflammatory compounds
JPH09503905A (ja) * 1993-07-15 1997-04-22 ネオゼ ファーマシューティカルス 糖組成物の合成方法
US5516665A (en) * 1993-09-13 1996-05-14 The Scripps Research Institute N-acetylgalactosaminyl or N-acetylglucosaminyl transfer using N-acetylglucosaminyl-1-phosphate or N-acetylgalactosaminyl-1-phosphate as precursor and glycosyl-nucleotide regeneration
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5728554A (en) * 1995-04-11 1998-03-17 Cytel Corporation Enzymatic synthesis of glycosidic linkages

Also Published As

Publication number Publication date
EP0972068A1 (en) 2000-01-19
US5945314A (en) 1999-08-31
CA2284731A1 (en) 1998-10-08
NO994771L (no) 1999-09-30
JP2001518783A (ja) 2001-10-16
WO1998044145A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
NO994771D0 (no) FremgangsmÕte ved fremstilling av oligosakkarider
NO985064L (no) FremgangsmÕte ved fremstilling av sildenafil
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
NO974316D0 (no) Fremgangsmåte ved fremstilling av avfasede katetre
NO20000189L (no) Fremgangsmõte for fremstilling av heparin
NO972240D0 (no) Fremgangsmåte ved fremstilling av N-fosfonometylglycin
NO996521L (no) Fremgangsmåte ved fremstilling av antiparasittisk middel
NO964482D0 (no) Fremgangsmåte ved fremstilling av doxorubicin
NO20023937D0 (no) Fremgangsmåte for fremstilling av substituert tiazolidindion
NO993912L (no) FremgangsmÕte for fremstilling av eprosartan
NO993913D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO20005424L (no) Fremgangsmåte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO20005425D0 (no) FremgangsmÕte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
NO994749D0 (no) FremgangsmÕte ved fremstillingen av tetraazamakrocykler
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO953459D0 (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
NO961577L (no) Fremgangsmåte for fremstilling av tre-polymer-kompositter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application